vWF aptamer formulations and methods for use

作者: Renta Hutabarat , Robert G. Schaub , James Gilbert

DOI:

关键词:

摘要: The invention relates to the formulation, dosing, administration and use of an aptamer antagonist therapeutic that binds von Willebrand Factor.

参考文章(78)
Mitsuyo Nagano, Tsuyoshi Kobayashi, Morikazu Kito, Ryota Yoshimoto, Akiko Tanaka, Naoyuki Fukuchi, Hiroshi Yamamoto, Koichi Ishii, Peptide having anti-thrombus activity and method of producing the same ,(1994)
Ken Hirose, Junko Matsushita, Shunsuke Kageyama, Hiroshi Yamamoto, Makoto Shiozaki, Pharmaceutical composition for the treatment of thrombocytopenia ,(2005)
Christian Fiedler, Friedrich Dorner, Artur Mitterer, Bernhard Fischer, Johann Eibl, A method of recovering highly purified vwf or factor viii/vwf-complex ,(1998)
Carol A. Fulcher, Theodore S. Zimmerman, Paul A. Foster, Protein fragments containing Factor VIII binding domain of von Willebrand Factor ,(1987)
Vilma Yuzbasiyan-Gurkan, George J. Brewer, Patrick J. Venta, William D. Schall, DNA encoding von Willebrand factor and methods of use ,(1997)
Renate Den-Bouwmeester, Friedrich Dorner, Artur Mitterer, Johann Eibl, Manfred Reiter, Peter Turecek, Hans-Peter Schwarz, Wolfgang Mundt, Uwe Schlokat, Bernhard Fischer, Falko-Guenter Falkner, Method for isolation of highly pure von willebrand factor ,(1997)
Vijay Vir Kakkar, Kalwant Singh Authi, Michael Finbarr Scully, Xinjie Lu, Bi- or multifunctional molecules based on a dendroaspin scaffold ,(1998)
Larry Gold, Rebecca Vanderslice, Daniel J. Schneider, Flow cell selex ,(1997)